The global response to the COVID-19 pandemic: how have immunology societies contributed?

Faith Osier; Jenny P Y Ting; John Fraser; Bart N Lambrecht; Marta Romano; Ricardo T Gazzinelli; Karina R Bortoluci; Dario S Zamboni; Arne N Akbar; Jennie Evans; Doug E Brown; Kamala D Patel; Yuzhang Wu; Ana B Perez; Oliver Pérez; Thomas Kamradt; Christine Falk; Mira Barda-Saad; Amiram Ariel; Angela Santoni; Francesco Annunziato; Marco A Cassatella; Hiroshi Kiyono; Valeriy Chereshnev; Alioune Dieye; Moustapha Mbow; Babacar Mbengue; Maguette D S Niang; Melinda Suchard

doi:10.1038/s41577-020-00428-4

The global response to the COVID-19 pandemic: how have immunology societies contributed?

Nat Rev Immunol. 2020 Oct;20(10):594-602. doi: 10.1038/s41577-020-00428-4. Epub 2020 Sep 10.

Authors

Faith Osier^{1

2}, Jenny P Y Ting³, John Fraser⁴, Bart N Lambrecht⁵, Marta Romano⁶, Ricardo T Gazzinelli⁷, Karina R Bortoluci⁸, Dario S Zamboni⁹, Arne N Akbar¹⁰, Jennie Evans¹¹, Doug E Brown¹¹, Kamala D Patel^{12

13}, Yuzhang Wu¹⁴, Ana B Perez¹⁵, Oliver Pérez¹⁶, Thomas Kamradt¹⁷, Christine Falk¹⁸, Mira Barda-Saad¹⁹, Amiram Ariel²⁰, Angela Santoni^{21

22}, Francesco Annunziato^{23

24}, Marco A Cassatella²⁵, Hiroshi Kiyono^{26

27

28}, Valeriy Chereshnev²⁹, Alioune Dieye³⁰, Moustapha Mbow³¹, Babacar Mbengue³¹, Maguette D S Niang³¹, Melinda Suchard^{32

33}

Affiliations

¹ Biosciences Department, KEMRI Wellcome, Kilifi, Kenya. fosier@kemri-wellcome.org.
² Parasitology Department, Heidelberg University Hospital, Heidelberg, Germany. fosier@kemri-wellcome.org.
³ Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, NC, USA. jenny_ting@med.unc.edu.
⁴ Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. j.fraser@auckland.ac.nz.
⁵ VIB-UGent Center for Inflammation Research, Ghent, Belgium. bart.lambrecht@ugent.be.
⁶ Sciensano, Brussels, Belgium.
⁷ Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. ricardo.gazzinelli@fiocruz.br.
⁸ Universidade Federal de São Paulo, São Paulo, Brazil.
⁹ Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.
¹⁰ Division of Infection and Immunity, University College London, London, UK. a.akbar@ucl.ac.uk.
¹¹ British Society for Immunology, London, UK.
¹² Department of Physiology and Pharmacology, University of Calgary, Calgary, AB, Canada. kpatel@ucalgary.ca.
¹³ Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada. kpatel@ucalgary.ca.
¹⁴ Institute of Immunology, Army Medical University, Chongqing, China. wuyuzhang@tmmu.edu.cn.
¹⁵ Pedro Kourí Institute, Havana, Cuba. anab@ipk.sld.cu.
¹⁶ Instituto de Ciencias Básicas y Preclínicas 'Victoria de Girón', Universidad de Ciencias Médicas de la Habana, Havana, Cuba.
¹⁷ Institute of Immunology, Jena, Germany. thomas.kamradt@med.uni-jena.de.
¹⁸ DZIF, Hannover Medical School, Hannover, Germany.
¹⁹ Laboratory of Molecular and Applied Immunology, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel. mira.barda-saad@biu.ac.il.
²⁰ Department of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
²¹ Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. angela.santoni@uniroma1.it.
²² Instituto Pasteur Italia, Cenci Bolognetti Foundation, Rome, Italy. angela.santoni@uniroma1.it.
²³ School of Medicine, University of Florence, Florence, Italy.
²⁴ Flow Cytometry Diagnostic Core, Careggi University Hospital, Florence, Italy.
²⁵ University of Verona, Verona, Italy.
²⁶ Division of Mucosal Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan. kiyono@ims.u-tokyo.ac.jp.
²⁷ Institute for Global Prominent Research, Graduate School of Medicine, Chiba University, Chiba, Japan. kiyono@ims.u-tokyo.ac.jp.
²⁸ Center for Mucosal Immunology, Allergy and Vaccines, Division of Gastroenterology, Department of Medicine, School of Medicine, University of California, San Diego, San Diego, CA, USA. kiyono@ims.u-tokyo.ac.jp.
²⁹ Institute of Immunology and Physiology, Ural Branch of Russian Academy of Sciences, Yekaterinburg, Russia. mchereshneva@mail.ru.
³⁰ Department of Immunology, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University of Dakar, Dakar, Senegal. alioune.dieye@ucad.edu.sn.
³¹ Department of Immunology, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University of Dakar, Dakar, Senegal.
³² National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa. melindas@nicd.ac.za.
³³ Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. melindas@nicd.ac.za.

Abstract

The COVID-19 pandemic is shining a spotlight on the field of immunology like never before. To appreciate the diverse ways in which immunologists have contributed, Nature Reviews Immunology invited the president of the International Union of Immunological Societies and the presidents of 15 other national immunology societies to discuss how they and their members responded following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antiviral Agents / chemical synthesis
Antiviral Agents / therapeutic use
Betacoronavirus / drug effects
Betacoronavirus / immunology
Betacoronavirus / pathogenicity
COVID-19 / epidemiology*
COVID-19 / immunology
COVID-19 / prevention & control
COVID-19 / therapy
COVID-19 Vaccines
Community-Institutional Relations
Coronavirus Infections / epidemiology*
Coronavirus Infections / immunology
Coronavirus Infections / prevention & control
Coronavirus Infections / therapy
Global Health / trends
Humans
International Cooperation*
Pandemics*
Patient Education as Topic / organization & administration
Personal Protective Equipment / supply & distribution
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / immunology
Pneumonia, Viral / therapy
SARS-CoV-2
Severe Acute Respiratory Syndrome / epidemiology*
Severe Acute Respiratory Syndrome / immunology
Severe Acute Respiratory Syndrome / therapy
Societies, Scientific / organization & administration*
Viral Vaccines / biosynthesis

Substances

Antiviral Agents
COVID-19 Vaccines
Viral Vaccines